Axcella Health Inc (NASDAQ:AXLA) Short Interest Update

Share on StockTwits

Axcella Health Inc (NASDAQ:AXLA) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totalling 113,100 shares, an increase of 17.9% from the February 27th total of 95,900 shares. Currently, 1.4% of the company’s shares are short sold. Based on an average daily trading volume, of 34,800 shares, the days-to-cover ratio is presently 3.3 days.

In other news, Director David R. Epstein purchased 12,800 shares of the stock in a transaction dated Thursday, February 27th. The stock was acquired at an average cost of $3.65 per share, for a total transaction of $46,720.00. Following the completion of the acquisition, the director now directly owns 66,098 shares in the company, valued at approximately $241,257.70. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have bought 17,465 shares of company stock valued at $69,689.

A number of hedge funds have recently made changes to their positions in the business. State Street Corp acquired a new position in Axcella Health during the fourth quarter valued at approximately $230,000. Geode Capital Management LLC acquired a new position in Axcella Health during the fourth quarter valued at approximately $155,000. Bank of New York Mellon Corp acquired a new position in Axcella Health during the fourth quarter valued at approximately $80,000. UBS Group AG lifted its position in Axcella Health by 1,168.2% during the fourth quarter. UBS Group AG now owns 19,073 shares of the company’s stock valued at $76,000 after buying an additional 17,569 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. acquired a new position in Axcella Health during the fourth quarter valued at approximately $69,000. 63.27% of the stock is currently owned by hedge funds and other institutional investors.

AXLA opened at $3.42 on Wednesday. The company’s 50 day simple moving average is $3.70 and its 200 day simple moving average is $4.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 11.19 and a current ratio of 11.19. Axcella Health has a 1 year low of $2.25 and a 1 year high of $15.99. The stock has a market capitalization of $60.33 million and a PE ratio of -0.71.

Axcella Health (NASDAQ:AXLA) last released its earnings results on Monday, March 23rd. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.64) by ($0.04). As a group, sell-side analysts expect that Axcella Health will post -1.23 earnings per share for the current fiscal year.

Separately, Zacks Investment Research upgraded shares of Axcella Health from a “hold” rating to a “buy” rating and set a $3.00 price target for the company in a report on Tuesday, March 24th. Five research analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and a consensus price target of $17.25.

Axcella Health Company Profile

There is no company description available for Axcella Health Inc

Recommended Story: Equal Weight Rating

Receive News & Ratings for Axcella Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcella Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Xinyuan Real Estate  to Release Earnings on Friday
Xinyuan Real Estate to Release Earnings on Friday
Constellation Brands  to Release Quarterly Earnings on Friday
Constellation Brands to Release Quarterly Earnings on Friday
PriceSmart  Set to Announce Quarterly Earnings on Wednesday
PriceSmart Set to Announce Quarterly Earnings on Wednesday
MSC Industrial Direct  Set to Announce Quarterly Earnings on Wednesday
MSC Industrial Direct Set to Announce Quarterly Earnings on Wednesday
Solaredge Technologies  Trading Down 0.9% After Analyst Downgrade
Solaredge Technologies Trading Down 0.9% After Analyst Downgrade
Melcor Real Estate Investment Trust  Hits New 12-Month Low Following Analyst Downgrade
Melcor Real Estate Investment Trust Hits New 12-Month Low Following Analyst Downgrade


© 2006-2020 Ticker Report